Abstract:Hepatitis B virus (HBV) expresses co-terminal large (L), middle (M), and small (S) envelope proteins containing preS1/preS2/S, preS2/S, and S domain alone, respectively. S and preS1 domains mediate sequential virion attachment to heparan sulfate proteoglycans and sodium taurocholate cotransporting polypeptide (NTCP), respectively, which can be blocked by anti-S and anti-preS1 antibodies. How anti-preS2 antibodies neutralize HBV infectivity remains enigmatic. The late stage of chronic HBV infection often selects for mutated preS2 translation initiation codon to prevent M protein expression, or in-frame preS2 deletions to shorten both L and M proteins. When introduced to infectious clone of genotype C or D, both M-minus mutations and most 5' preS2 deletions sustained virion production. Such mutant progeny viral particles were infectious in NTCP-reconstituted HepG2 cells. Neutralization experiments were performed on the genotype D clone. Although remaining susceptible to anti-preS1 and anti-S neutralizing antibodies, M-minus mutants were only partially neutralized by two anti-preS2 antibodies tested while preS2 deletion mutants were resistant. By infection experiments using viral particles with lost versus increased M protein expression, or a neutralization escaping preS2 deletion only present on L or M protein, we found that both full-length L and M proteins contributed to virus neutralization by the two anti-preS2 antibodies. Thus, immune escape could be a driving force for the selection of M-minus mutations, and especially preS2 deletions. The fact that both L and M proteins could mediate neutralization by anti-preS2 antibodies may shed light on the underlying molecular mechanism.IMPORTANCEThe large (L), middle (M), and small (S) envelope proteins of hepatitis B virus (HBV) contain preS1/preS2/S, preS2/S, and S domain alone, respectively. The discovery of heparan sulfate proteoglycans and sodium taurocholate cotransporting polypeptide (NTCP) as the low- and high-affinity HBV receptors could explain neutralizing potential of anti-S and anti-preS1 antibodies, respectively, but how anti-preS2 neutralizing antibodies work remains enigmatic. In this study, we found two M-minus mutants in the context of genotype D partially escaped two anti-preS2 neutralizing antibodies in NTCP-reconstituted HepG2 cells, while several naturally occurring preS2 deletion mutants escaped both antibodies. By point mutations to eliminate or enhance M protein expression, and by introducing preS2 deletion selectively to L or M protein, we found binding of anti-preS2 antibodies to both L and M proteins contributed to neutralization of wild-type HBV infectivity. Our finding may shed light on the possible mechanism(s) whereby anti-preS2 antibodies neutralize HBV infectivity.

Lost small envelope protein expression from naturally occurring preS1 deletion mutants of hepatitis B virus is often accompanied by increased HBx and core protein expression as well as genome replication

Role of Small Envelope Protein in Sustaining the Intracellular and Extracellular Levels of Hepatitis B Virus Large and Middle Envelope Proteins

5' preS1 mutations to prevent large envelope protein expression from hepatitis B virus genotype A or genotype D markedly increase polymerase-envelope fusion protein

Expression Level Of Small Envelope Protein In Addition To Sequence Divergence Inside Its Major Hydrophilic Region Contributes To More Efficient Surface Antigen Secretion By Hepatitis B Virus Subgenotype D2 Than Subgenotype A2

High-level Expression of Human HBV Pres Gene in Silkworm ( Bombyx Mori ) Cells by Mutation of the 5'-End Coding Sequence

Two-dimensional Blue Native/SDS-PAGE Analysis Reveals Heat Shock Protein Chaperone Machinery Involved in Hepatitis B Virus Production in HepG2.2.15 Cells

Naturally Occurring 5' Pres1 Deletions Markedly Enhance Replication And Infectivity Of Hbv Genotype B And Genotype C

The Envelope Gene of Hepatitis B Virus is Implicated in Both Differential Virion Secretion and Genome Replication Capacities Between Genotype B and Genotype C Isolates.

Quantitative Proteomic Analysis of Exosome Protein Content Changes Induced by Hepatitis B Virus in Huh-7 Cells Using Silac Labeling and Lc-Ms/Ms

Mutations in Precore and Core Promoter Region of HBV in Patients with Hepatic Failure.

Mutations in hepatitis B virus DNA from patients with coexisting HBsAg and anti-HBs.

Hepatitis B virus enhancer 1 activates preS1 and preS2 promoters of integrated HBV DNA impairing HBsAg secretion

Gene-expression Profiles of a Hepatitis B Small Surface Antigen-Secreting Cell Line Reveal Upregulation of Lymphoid Enhancer-Binding Factor 1

Functional Characterization of Hepatitis B Virus Core Promoter Mutants Revealed Transcriptional Interference among Co-Terminal Viral Mrnas.

Cmv Promoter and the Mouse Albumin Promoter and Enhancer Triggered the Elevation of Hepatitis B Virus Envelope Polypeptides

PreS1BP mediates inhibition of Hepatitis B virus replication by promoting HBx protein degradation

Hepatit is B Virus S Promoter Delet ion in Hepatocellular Carcinoma

Evaluation of Hepatitis B Viral Replication and Proteomic Analysis of HepG2.2.15 Cell Line after Knockdown of HBx

The Role of Hepatitis B Virus Surface Proteins in Regulating the Maturation and Secretion of Complete and Incomplete Virions.

Serum protein expression patterns in detecting a new viral protein in HBeAg-negative chronic hepatitis B.

Both middle and large envelope proteins can mediate neutralization of hepatitis B virus infectivity by anti-preS2 antibodies: escape by naturally occurring preS2 deletions